Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.
<h4>Purpose</h4>To assess the efficacy of combination chemotherapy with nafamostat mesilate, gemcitabine and S-1 for unresectable pancreatic cancer patients.<h4>Materials and methods</h4>The study was conducted as a single-arm, single center, institutional review board-approved phase II trial. Patie...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science (PLoS)
2022-01-01
|
| Serier: | PLoS ONE |
| Online adgang: | https://doi.org/10.1371/journal.pone.0267623 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|